skip page navigationOregon State University

Myrna Y. Munar, Pharm.D.

Associate Professor, Pharmacotherapy
Department of Pharmacy Practice

Contact Information

College of Pharmacy
Oregon Health & Science University
3303 SW Bond Ave., CH12C
Portland, OR 97239
Phone: 503-494-5164
munarm@ohsu.edu

Education

Board Certified Pharmacotherapy Specialist, 1995; Recertified 2002
Philadelphia College of Pharmacy and Science, Fellowship in Oncology/Pharmacokinetics, 1988
Good Samaritan Hospital and Medical Center, Portland, OR, ASHP-Accredited Residency, 1986
University of Southern California, Pharm.D., 1985; B.S., 1981

Research

Myrna Munar is interested in research in the area of pharmacokinetics.

Selected Publications

Murna Y. Munar, Harleen Singh. The use of wireless laptop computers for Computer-Assisted Learning in Pharmacokinetics.

Lindau MS, Munar MY. Use of duct tape occlusion in the treatment of recurrent molluscum contagiosum. Pediatric Dermatology, letter. 2004;21(5):609.

Beer TM, Munar M, Henner WD. A phase I trial of pulse calcitriol in patients with refractory malignancies: pulse dosing permits substantial dose escalation. Cancer. 2001;91:2431-9.

Brunner LJ, Pai K, Munar MY, Lande MB, Olyaei AJ, Mowry JA. Effect of grapefruit juice on cyclosporine A pharmacokinetics in pediatric renal transplant patients. Pediatric Transplantation. 2000;4:313-321.

Brunner LJ, McGuinness M, Meyer M, Munar MY. Acute acetaminophen toxicity during chronic alcohol use. Hospital Pharmacist. 1999;24(9):11-19.

Meyer M, Munar MY, Kohlhepp S, Bryant R. Meropenem pharmacokinetics in a patient with multiorgan failure from Meningococcemia undergoing CVVHDF. American Journal of Kidney Diseases. 1999;33(4):790-795.

Brunner LJ, Munar MY, Vallian J, Wolfson M, Stennett DJ, Meyer MM, Bennett WM. Interaction between cyclosporine and grapefruit juice requires chronic ingestion in stable renal transplant patients. Pharmacotherapy. 1998;18(1):23-29.

Munar MY, Doyle IC, Meyer MM. Cyclosporine and vancomycin disposition during continuous venovenous hemodiafiltration. Annals of Pharmacotherapy. 1995;29:374-377.

Burdmann EA, Andoh TF, Rosen S, Lindsley J, Munar MY, Elzinga LW, Bennett WM. Experimental nephrotoxicity, hepatotoxicity and pharmacokinetics of cyclosporin G versus cyclosporin A. Kidney International. 1994;45:684-691.

Meyer MM, Munar MY, Udeaja J, Bennett WM. Efficacy of area-under-the-curve cyclosporine monitoring in renal transplantation. Journal of the American Society of Nephrology. 1993;4:1306-1315.

Henell KR, Cheever JM, Kimball JA, Lye WC, Munar MY, Misiti J, Vitow C, Norman DJ. OKT4a (murine IGGa anti-CD4 monoclonal antibody) in human organ transplantation: Pharmacokinetics and peripheral pharmacodynamics. Transplantation Proceedings. 1993;25(1):800-801.

Kremer D, Munar MY, Kohlhepp S, Gilbert DN, Young EW, Bennett WM. Zidovudine (AZT) pharmacokinetics in patients undergoing continuous ambulatory peritoneal dialysis. Pharmacotherapy. 1992;12(1):56-60.

Munar MY, Lawson LA, Samuels P, Gibson GA. Gentamicin pharmacokinetics in postpartum women with endomyometritis. DICP, Annals of Pharmacotherapy. 1991;25:1306-1309.

Munar MY, Elzinga L, Brummett R, Golper T, Bennett WM. The effect of tobramycin on the renal handling of vancomycin. Journal of Clinical Pharmacology. 1991;31:618-623.

Swan S, Munar MY, Wigger M, Bennett WM. Ganciclovir pharmacokinetics in a patient undergoing hemodialysis. American Journal of Kidney Diseases. 1991;17(1):69-72.

Munar MY, Scholtz JM. Is tamoxifen useful in the treatment of stage I breast cancer? Clinical Pharmacy. 1988;7(9):640-643.